Top

Journal of Autism and Developmental Disorders

Gepubliceerd in:

16-02-2017 | Original Paper

Medical Conditions and Demographic, Service and Clinical Factors Associated with Atypical Antipsychotic Medication Use Among Children with An Autism Spectrum Disorder

Auteurs: Johanna K. Lake, Danica Denton, Yona Lunsky, Amy M. Shui, Jeremy Veenstra-VanderWeele, Evdokia Anagnostou

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 5/2017

Abstract

This study aimed to describe rates of antipsychotic medication use and the association between their use and demographics, clinical variables, and the use of behavioral/education services among children with ASD. For children with ASD ages 2–11 (n = 4749) and those 12–17 (n = 401), 5.4 and 17.7% were prescribed at least one atypical antipsychotic medication respectively. In the multivariable model of young children, older age, use of multiple psychotropic medications, prior ASD diagnosis, non-white Hispanic race/ethnicity, and oppositional defiant problems were associated with antipsychotic use. Among older children, only older age was associated with antipsychotic use. In at least one age group, antipsychotic medication use was also related to behaviour, family and occupational therapy, public insurance, site region, externalizing problems, body mass index, and sleep and gastrointestinal problems.

vorige artikel Speech Acts During Friends’ and Non-friends’ Spontaneous Conversations in Preschool Dyads with High-Functioning Autism Spectrum Disorder versus Typical Development

volgende artikel Potential Risk Factors for the Development of Self-Injurious Behavior among Infants at Risk for Autism Spectrum Disorder

Achenbach, T. M., & Rescorla, L. A. (2000). Manual for the ASEBA Preschool forms and Profiles. Burlington, VT: University of Vermont Department of Psychiatry.

Almandil, N. B., Liu, Y., Murray, M. L., Besag, F. M., Aitchison, K. J., & Wong, I. C. (2013). Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: a systematic review and meta-analysis. Pediatric Drugs, 15(2), 139–50.CrossRefPubMed

Aman, M. G., McDougle, C. J., Scahill, L., Handen, B., Arnold, L. E., Johnson, C., … & Wagner, A. (2009). Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 1143–54.CrossRefPubMed

Barnard, L., Young, A. H., Pearson, J., Geddes, J., & O’brien, G. (2002). A systematic review of the use of atypical antipsychotics in autism. Journal of Psychopharmacology, 16(1), 93–101.CrossRefPubMed

Coury, D. L., Anagnostou, E., Manning-Courtney, P., Reynolds, A., Cole, L., McCoy, R., Whitaker, A. & Perrin, J. M. (2012). Use of psychotropic medication in children and adolescents with autism spectrum disorders. Pediatrics, 130(Supplement 2), S69–76.CrossRefPubMed

Egan, A. M., Dreyer, M. L., Odar, C. C., Beckwith, M., & Garrison, C. B. (2013). Obesity in young children with autism spectrum disorders: Prevalence and associated factors. Childhood Obesity, 9, 125–31.CrossRefPubMed

Findling, R. L., Horwitz, S. M., Birmaher, B., Kowatch, R. A., Fristad, M. A., Youngstrom, E. A., ... & Arnold, L. E. (2011). Clinical characteristics of children receiving antipsychotic medication. Journal of Child and Adolescent Psychopharmacology, 21(4), 311–19.CrossRefPubMedPubMedCentral

Frazier, T. W., Shattuck, P. T., Narendorf, S. C., Cooper, B. P., Wagner, M., & Spitznagel, E. L. (2011). Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 21(6), 571–79.CrossRefPubMedPubMedCentral

Frazier, T. W., Youngstrom, E. A., Haycook, T., Sinoff, A., Dimitriou, F., Knapp, J., & Sinclair, L. (2010). Effectiveness of medication combined with intensive behavioral intervention for reducing aggression in youth with autism spectrum disorder. Journal of Child and Adolescent Psychopharmacology, 20(3), 167–77.CrossRefPubMed

Gleason, M. M., Egger, H. L., Emslie, G. J., Greenhill, L. L., Kowatch, R. A., Lieberman, A. F., ... & Zeanah, C. H. (2007). Psychopharmacological treatment for very young children: Contexts and guidelines. Journal of the American Academy of Child & Adolescent Psychiatry, 46, 1532–72.CrossRef

Hassiotis, A., Robotham, D., Canagasabey, A., Romeo, R., Langridge, D., Blizard, R., Murad, S., & King, M. (2009). Randomized, single-blind, controlled trial of a specialist behavior therapy team for challenging behavior in adults with intellectual disabilities. The American Journal of Psychiatry, 166, 1278–85.CrossRefPubMed

Hilt, R. J., Chaudhari, M., Bell, J. F., Wolf, C., Koprowicz, K., & King, B. H. (2014). Side effects from use of one or more psychiatric medications in a population-based sample of children and adolescents. Journal of Child and Adolescent Psychopharmacology, 24(2), 83–9.CrossRefPubMedPubMedCentral

Jensen, P. S., Hinshaw, S. P., Swanson, J. M., Greenhill, L. L., Conners, C. K., Arnold, L. E., ... & March, J. S. (2001). Findings from the NIMH multimodal treatment study of ADHD (MTA): Implications and applications for primary care providers. Journal of Developmental & Behavioral Pediatrics, 22(1), 60–73.CrossRef

Kaplan, G., & McCracken, J. T. (2012). Psychopharmacology of autism spectrum disorders. Pediatric Clinics of North America, 59(1), 175–87.CrossRefPubMed

Lòpez-De Fede, A., Vyavaharkar, M., & Bellinger, J. D. (2014). Antipsychotic prescriptions for children aged 5 years or younger. SAGE Open, 4(4), 2158244014555116.CrossRef

Maayan, L., & Correll, C. U. (2011). Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents. Journal of Child and Adolescent Psychopharmacology, 21(6), 517–35.CrossRefPubMed

Mandell, D. S., Morales, K. H., Marcus, S. C., Stahmer, A. C., Doshi, J., & Polsky, D. E. (2008). Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders. Pediatrics, 121, 441–48.CrossRef

Martínez-Ortega, J. M., Funes-Godoy, S., Díaz-Atienza, F., Gutiérrez-Rojas, L., Pérez-Costillas, L., & Gurpegui, M. (2013). Weight gain and increase of body mass index among children and adolescents treated with antipsychotics: a critical review. European Child & Adolescent Psychiatry, 22(8), 457–79.CrossRef

Medicaid Medical Directors Learning Network. (2010). Antipsychotic medication use in medicaid children and adolescents: Report and resource guide from a 16-state study. Medicaid medical directors learning network and rutgers center for education and research on mental health therapeutics. Retrieved from: http://rci.rutgers.edu/~cseap/ MMDLNAPKIDS.html.

Myers, S. M. (2007). The status of pharmacotherapy for autism spectrum disorders. Expert Opinion on Pharmacotherapy, 8, 1579–603.CrossRefPubMed

Myers, S. M., & Plauche Johnson, C. (2007). Management of children with autism spectrum disorders. Pediatrics, 120, 1162–82.CrossRefPubMed

National Institute for Health and Care Excellence. (2014). NICE quality standard 51. guidance.nice.org.uk/qs51.

Owens, J. A., Spirito, A., & McGuinn, M. (2000). The Children’s sleep habits questionnaire (CSHQ): Psychometric properties of a survey instrument for school-aged children. Sleep, 23(8), 1043–51.PubMed

Park, S. Y., Cervesi, C., Galling, B., Molteni, S., Walyzada, F., Ameis, S. H., ... & Correll, C. U. (2016). Antipsychotic use trends in youth with autism spectrum disorder and/or intellectual disability: A meta-analysis. Journal of the American Academy of Child & Adolescent Psychiatry, 55(6), 456–68.CrossRef

Peters, B., Williams, K. C., Gorrindo, P., Rosenberg, D., Lee, E. B., Levitt, P., & Veenstra-VanderWeele, J. (2014). Rigid–compulsive behaviors are associated with mixed bowel symptoms in autism spectrum disorder. Journal of Autism and Developmental Disorders, 44(6), 1425–32.CrossRefPubMedPubMedCentral

Posey, D. J., & McDougle, J. (2000). The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders. Harvard Review of Psychiatry, 8, 45–63.CrossRefPubMed

Rosenberg, R. E., Mandell, D. S., Farmer, J. E., Law, J. K., Marvin, A. R., & Law, P. A. (2010). Psychotropic medication use among children with autism spectrum disorders enrolled in a National Registry, 2007–2008. Journal of Autism and Developmental Disorders, 40, 342–51.CrossRefPubMed

Spencer, D., Marshall, J., Post, B., Kulakodlu, M., Newschaffer, C., Dennen, T., Azocar, F., & Jain, A. (2013). Psychotropic medication use and polypharmacy in children with autism spectrum disorders. Pediatrics, 132(5), 833–40.CrossRefPubMedPubMedCentral

Vitiello, B., Correll, C., van Zwieten-Boot, B., Zuddas, A., Parellada, M., & Arango, C. (2009). Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns. European Neuropsychopharmacology, 19(9), 629–35.CrossRefPubMed

Volkmar, Fred, et al. (2014). Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 53(2), 237–57.CrossRef

Yen, J., Grover, M., & Mao, A. (2011). Antipsychotics and autism: Weight, metabolism, and safety. Child and Adolescent Psychopharmacology News, 16(1), 1–11.CrossRef

Zuckerman, K. E., Hill, A. P., Guion, K., Voltolina, L., & Fombonne, E. (2014). Overweight and obesity: Prevalence and correlates in a large clinical sample of children with autism spectrum disorder. Journal of Autism and Developmental Disorders, 44, 1708–19.CrossRefPubMedPubMedCentral

Titel: Medical Conditions and Demographic, Service and Clinical Factors Associated with Atypical Antipsychotic Medication Use Among Children with An Autism Spectrum Disorder
Auteurs: Johanna K. Lake
Danica Denton
Yona Lunsky
Amy M. Shui
Jeremy Veenstra-VanderWeele
Evdokia Anagnostou
Publicatiedatum: 16-02-2017
Uitgeverij: Springer US
Gepubliceerd in: Journal of Autism and Developmental Disorders / Uitgave 5/2017
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI: https://doi.org/10.1007/s10803-017-3058-8

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 5/2017

Fred R. Volkmar, Brian Reichow, and James McPartland (Eds): Adolescents and Adults with Autism Spectrum Disorder

Brief Report: Using iPads for Self-Monitoring of Students with Autism

Joint-Attention and the Social Phenotype of School-Aged Children with ASD

Depression in Parents of Children Diagnosed with Autism Spectrum Disorder: A Claims-Based Analysis

Atypical Processing of Gaze Cues and Faces Explains Comorbidity between Autism Spectrum Disorder (ASD) and Attention Deficit/Hyperactivity Disorder (ADHD)

Developing Autism Screening Criteria for the Brief Infant Toddler Social Emotional Assessment (BITSEA)